{
    "nct_id": "NCT04020978",
    "official_title": "Pilot Study Using Parametric PET to Assess Early Treatment Response to Targeted Therapy for Genitourinary Cancer (GUC)",
    "inclusion_criteria": "* Patients with pathologically confirmed GUC. For those patients whose primary kidney cancer is removed, they must have index metastatic cancer lesion(s) within the PET field of view for 18F-FDG parametric PET/CT analysis to determine response.\n* Patients are scheduled for targeted cancer therapy, including sunitinib, pazopanib, cabozantinib, everolimus, and others.\n* Ability to understand and willingness to sign an informed consent form.\n* Ability to adhere to the study visit schedule and other protocol requirements.\n* Men and women ≥21 years of age.\n* Life expectancy ≥ 6months.\n* Female subjects who are of non-reproductive potential (i.e., post-menopausal by history - no menses for ≥1 year; OR history of hysterectomy; OR history of bilateral tubal ligation; OR history of bilateral oophorectomy). Or, female subjects of childbearing potential must have a negative serum or urine pregnancy test within 72 hours prior to the first drug administration.\n* Male and female subjects who agree to use highly effective method of birth control (e.g., implants, injectables, birth control pills with two hormones, intrauterine devices [IUDs], complete abstinence or sterilized partner, and female sterilization) and a barrier method (e.g., condoms, vaginal ring, sponge, etc.) during the period of therapy and for 90 days after the last dose of drug.\n* For the minority cohort, subject must be a member of a Federally recognized racial/ethnic minority population to include: African Americans or Black; Native American; Alaska Native; Native Hawaiian or other Pacific Islander; Asian American; Hispanic or Latino. This will be verified through self-reporting by the subject.\nHealthy volunteers allowed\nMust have minimum age of 21 Years\nMust have maximum age of 100 Years",
    "exclusion_criteria": "* Pregnant or lactating women.\n* Any condition that would prohibit the understanding or rendering of informed consent.\n* Any medical condition including additional malignancies, laboratory abnormalities, or psychiatric illness that would prevent the subject from participating and adhering to study related procedures.\n* Prior treatment with any investigational drug within the previous 4 weeks\n* Unable to lie supine for 1-hour imaging with PET\n* Prisoners",
    "miscellaneous_criteria": ""
}